Skip to main content
L

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 436 across all filing types
Latest filing 2026-04-22 M&A Activity
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Updated second court date and indicative timetable 2 pages 200.8KB
M&A Activity Classification · 1% confidence The document is an ASX announcement outlining updated court dates and an indicative timetable for a proposed acquisition of Cannatrek Ltd by way of a scheme of arrangement under the Corporations Act. It pertains directly to M&A activity and takeover implementation steps rather than a general report, earnings release, or regulatory filing. This falls squarely under M&A Activity (Code: TAR).
2026-04-22 English
Results of General Meeting 2 pages 510.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an ASX announcement detailing the results of a General Meeting held on 22 April 2026, listing each resolution, the proxy votes for, against, abstentions, and whether each resolution was passed. This fits exactly the category of Declaration of Voting Results & Voting Rights Announcements (code DVA).
2026-04-21 English
Scheme Update 2 pages 178.4KB
M&A Activity Classification · 1% confidence The document is an ASX announcement regarding Little Green Pharma’s proposed acquisition of Cannatrek by way of a scheme of arrangement (a merger/takeover process). It discusses postponement of shareholder resolutions, court hearing dates, and updated timetables relevant to an M&A transaction under the Corporations Act. This clearly falls under the M&A Activity category (merger proposals or takeover bids).
2026-04-20 English
Scheme Approved by Cannatrek Shareholders 3 pages 159.9KB
Regulatory Filings
2026-04-09 English
Supplementary Scheme Booklet 13 pages 610.1KB
Regulatory Filings
2026-03-31 English
Dispatch of Supplementary Scheme Booklet 3 pages 306.6KB
Regulatory Filings
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.